Pseudomonas aeruginosa en 1997

Feuillets de Biologie

Volumn 38, Issue 214, 1997, Pages 11-22

  Cavallo, J D ^a   Gerome, P ^a   Fabre, R ^a  

^a HÔPITAL D'INSTRUCTION DES ARMÉES ROBERT PICQUÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; UNINDEXED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL INFECTION; HUMAN; PATHOPHYSIOLOGY; PSEUDOMONAS AERUGINOSA; REVIEW;

EID: 0031051024     PISSN: 04282779     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (64)

1. AGGER W.-A., MARDAN A. - Pseudomonas aeruginosa infections of intact skin. Clin. Infect. Dis., 1995, 20, 302-308.
2. ARBEIT R.-T. - Laboratory procedures for the epidemiologic analysis of microorganisms. In Manual of Clinical Microbiology, 6th ed., P.-R. Murray, E.-J. Baron, M.-A. Pfaller, F.-C. Tenover and R.-H. Yolker (Ed). American Society for Microbiology, Washington, D.C, 1995, pp 190-208.
3. ARONOFF S.-C., SCHLAES D.-M. - Factors that influence the evolution of β-lactam resistance in β-lactamase-inducible strains of Enterobacter cloacae and Pseudomonas aeruginosa. J. Infect. Dis., 1987, 155, 936-941.
4. ASSOCIATION INTERNATIONALE POUR LA RECHERCHE EN HYGIÈNE HOSPITALIÈRE - Première année de surveillance continue des infections nosocomiales, étude Européenne 1990 : Résultat et analyse. Bulletin de l'AIRHH, 1991, 3, fascicule 2.
5. BARRY A.-L., RELLER L.-B., MILLER G.-H., WASHINGTON J.-A., SCHOENKNECT F.-D., PETERSON L.-R., HARE R.-S., KNAPP C. - Revision of standards for adjusting the cation content of Mueller Hinton broth for testing susceptibility of Pseudomonas aeruginosa to aminoglycosides. J. Clin. Microbiol., 1992, 30, 585-589.
6. BARTH A.-L., PITT T.-L. - Auxotrophic variants of Pseudomonas aeruginosa are selected from prototrophic wild-type strains in respiratory infections in patients with cystic fibrosis. J. Clin. Microbiol., 1995, 33, 37-40.
7. BERT F., BRUNEAU B., LAMBERT-ZECHOVSKY N., BRANGER C. - Etude épidémiologique de la sensibilité aux antibiotiques de Pseudomonas aeruginosa. Path. Biol., 1994, 42, 491-497.
8. BISBE J., GATELL J.-M., PUIG J., MALLOLAS J., MARTINEZ J.-A., JIMENEZ M.-T., SORIANO E. - Pseudomonas aeruginosa bacteremia : univariate and multivariate analysis of factors influencing the prognosis in 133 episods. Rev. Infect. Dis., 1988, 10, 629-635.
9. BODEY G.-P., BOLIVAR R., FAINSTEIN V., JADEJA E. - Infections caused by Pseudomonas aeruginosa. Rev. Infect. Dis., 1983, 5, 279-313.
10. BROOK I., FRAZIER E.-H., THOMPSON D.-H. - Aerobic and anaerobic microbiology of external otitis. Clin. Infect Dis., 1992, 15, 955-958.
11. BUISSON Y., NIZOU J.-Y., TALARMIN A., MEYRAN M. - Diffusion à l'hôpital d'un phénotype de Pseudomonas aeruginosa produisant une bêta-lactamase fortement inductible in vitro par l'acide clavulanique. Path. Biol., 1992, 40, 566-572.
12. BÜSCHER K.-H., CULLMANN W., DICK W., OPFERKUCH W. - Imipenem resistance in Pseudomonas aeruginosa resulting from diminished expression of an outer membrane protein. Antimicrob. Agents Chemother., 1987, 31, 703-708.
13. BUSH K., JACOBY G.-A., MEDEIROS A.-A. - A fractionnal scheme for β-lactamases and its correlation with molecular structure. Antimicrob. Agents Chemother., 1995, 39, 1211-1233.
14. CAMBAU E., GUTMANN L. - Mechanisms of resistance to quinolones Drugs., 1993, 45, 15-23.
15. CAMBAU E., PERANI E., DIB C., PETINON C., TRIAS J., JARLIER V. - Role of mutations in DNA gyrase genes in ciprofloxacin resistance of Pseudomonas aeruginosa susceptible or resistant to imipenem. Antimicrob. Agents Chemother., 1995, 39, 2248-2252.
16. CRYZ Jr S.-J., WEDGWOOD J., LANG A.-B. - Immunization of non colonized patients against Pseudomonas aeruginosa. J. Infect. Dis., 1994, 169, 1159-1162.
17. DELISLE F., LESAGE D. - Pseudomonas aeruginosa.In « L'antibiogramme automatisé », P. Courvalin, J.-P. Flandrois, F. Goldstein, A. Philippon, C. Quentin et J. Sirot (eds).mpc/Vigot. Paris, 1988, pp. 89-96.
18. DROPULIC L.-K., LESLIE J.-M., ELDRED L.-J., ZENILMAN J., SEARS C.-L. - Clinical manifestations and risk factors of Pseudomonas aeruginosa infection in patients with AIDS. J. Infect. Dis., 1994, 171, 930-937.
19. ELACHOUNI A., VERSCHRAEGEN G., CLAEYS G., DEVLEESCHOUWER M., GODARD C., VANEECHOUTTE M. -Pseudomonas aeruginosa serotype O 12 outbreak studied by arbitrary primer PCR. J. Clin. Microbiol., 1994, 32, 666-671.
20. EMORI T.-G., GATES R.-P. - An overview of nosocomial infections, including the role of the microbiology laboratory. Clin. Microbiol. Rev., 1993, 6, 428-442.
21. EORTC International Antimicrobial Cooperative Group. - Ceftazidime combined with short and long course of amikacin for empirical therapy of gram-negative bacteremia in cancer patients with granulocytopénia. N. England J. Med., 1987, 317, 1692-1698.
22. EPIIC STUDY (European Prevalence of Infections In Intensive Care Units) - Infections nosocomiales : la carte Européenne. Pharmacien Hôpital, 1993, 23, 18.
23. FICHTENBAUM C.-J., WOELTJE K.-F., POWDERLY W.-G. - Serious Pseudomonas aeruginosa infections in patients infected with human immunodeficiency virus : a case-control study. Clin. Infect. Dis., 1994, 19, 417-422.
24. GATES M.-L., SANDERS C.-C., GOERING R.-V., SANDERS E. Jr. - Evidence for multiple forms of type I chromosomal β-lactamase in Pseudomonas aeruginosa. Antimicrob. Agents Chemother., 1986, 30, 453-457.
25. G.E.R.P.B. - Surveillance de la résistance de Pseudomonas aeruginosa aux antibiotiques en milieu hospitalier. Lett Infectiol., 1995, X, n° 11, 402-404.
26. GILLIGAN P.-H. - Pseudomonas and Burkhorlderia In Manual of Clinical Microbiology, 6th ed., P.-R. Murray, E.-J. Baron, M.-A. Pfaller. F.-C. Tenover and R.-H. Yolker (Ed) American Society for Microbiology, Washington, D.C, 1995, pp 509-518.
27. HALL L.-M.-C., LIVERMORE D.-M., GUR D., AKOVA M., AKALIN H.-E. - OXA-11, an extended-spectrum variant of OXA-10 (PSE-2), β-lactamase from Pseudomonas aeruginosa. Antimicrob. Agents Chemother., 1993, 37, 1637-1644.
28. HILF M., YU V.-L., SHARP J., ZURAVIEFF J.-J., KORVICK J -A., MUDER R.-R. - Antibiotic therapy for Pseudomonas aeruginosa bacteriemia : outcome correlations in a prospective study of 200 patients. Am. J. Med., 1989, 87, 540-546.
29. HOLLAND S.-P., PULIDO J.-S., SHIRES T.-K., COSTERTON J.-W. - Pseudomonas aeruginosa ocular infections. In Pseudomonas aeruginosa : the opportunist, Pick Jr R.-B.(ed.), CRC Press, Inc. Boca Raton, Fla, 1993, pp. 159-176.
30. JARVIS W.-R., MARTONE W.-J. - Predominant pathogens in hospital infections Journal of Antimicrobial Chemotherapy, 1992, 29, Suppl. A, 19-24.
31. KERSULYTE D., STRUELENS M.-J., DEPLANO A., BERG D.-E. Comparison of arbitrarily primed PCR and macrorestriction (Pulsed-field gel electrophoresis) typing of Pseudomonas aeruginosa strains from cystic fibrosis patients. J. Clin. Microbiol., 1995, 33, 2216-2219.
32. KOBAYASHI I., HASEGAWA M., MIYAZAKI S., NISHIDA M., GOTO S. - In vitro and in vivo changes of serotype in Pseudomonas aeruginosa isolates by anti-pseudomonal drugs. J. Antibiotics, 1994, 47, 72-79.
33. KORVICK J., YU W. - Antimicrobial agents therapy for Pseudomonas aeruginosa. Antimicrob. Agents Chemother., 1991, 35, 2167-2172.
34. LI X.-Z., MA D., LIVERMORE D.-M., NIKAIDO H. - Role of efflux pump(s) in intrinsic resistance of Pseudomonas aeruginosa: active efflux as a contributing factor to β-lactam resistance. Antimicrobial Agents and Chemotherapy, 1994, 38, 1742-1752.
35. LIVERMORE D.-M. - Interplay of impermeability and chromosomal β-lactamase activity in imipenem-resistant Pseudomonas aeruginosa. Antimicrob. Agents Chemother., 1992, 36, 2046-2048.
36. MAHENTHIRALINGAM E., CAMPBELL M.-E., SPEERT D.-P. - Non-motility and phagocytic resistance of Pseudomonas aeruginosa isolates from chronically colonized patients with cystic fibrosis. Infect. Immun., 1994, 62, 596-605.
37. MENDELSON M.-H., GURTMAN A , SZABO S., NEIBART E., MEYERS B.-R , POLICAR M., CHEUNG T.-W., LILLIENFELD D., HAMMER G., REDDY S., CHOI K., HIRSCHMAN S.-Z. Pseudomonas aeruginosa bacteremia in patients with AIDS. Clin. Infect Dis., 1994, 18, 886-895.
38. MEYER Ph., GUERIN J.-M., LEVY C., HABIB Y. - Sinusites aigues nosocomiales à pyocyanique. Med. Mal. Infect., 1988, 3, 159-162.
39. MICHEL-BRIAND Y. - Infections à bacille pyocyanique. Editions techniques, Encycl. Med. Chir. (Paris-France), Maladies infectieuses ; 8-316A-10, 1992, 14 p.
40. MICHEL-BRIAND Y., ALKHALAF-HADDAD B., BONNIN M. - Pseudomonas aeruginosa et antibiotiques. Bull. Inst. Pasteur, 1989, 87, 125-170.
41. MICHEL-BRIAND Y., GRANDGUILLOT M. - Facteurs de pathogénicité de Pseudomonas aeruginosa et critères permettant de valider son pouvoir pathogène. Lett. Infectiol., 1991, VI, n° 1, 3-6.
42. MILATOVIC D., BRAVENY I. - Development of resistance during antibiotic therapy. Eur. J. Clin. Microbiol, 1987, 6, 234-244.
43. MILLER G.-H., SABATELLI F.-J., NAPLES L., HARE R.-S., SHAW K.-J. AND THE AMINOGLYCOSIDE RESISTANCE STUDY GROUPS. - The most frequently occuring aminoglycoside resistance mechanisms - Combined results of surveys in eight regions of the world. J. Chemother, 1995, 7, Suppl. 2: 17-30.
44. MORRIN M., REEN D.-J. - Inhibition of the adherence of Pseudomonas aeruginosa to epithelial cells by IgG subclass antibodies. J. Med. Microbiol. 1993, 39, 459-466.
45. MORRISON A., WENZEL R.-P.- Epidemiology of infections due to Pseudomonas aeruginosa. Rev. Infect Dis, 1984, 6, Suppl. 3: S627-S642.
46. NIKAIDO H. - Prevention of drug access to bacterial targets: permeability barriers and active efflux. Science, 264, 382-388.
47. NORDMANN P., RONCO E., NAAS T., DUPORT C., MICHEL BRIAND Y., LABIA R. - Characterization of a novel extended-spectrum β-lactamase from Pseudomonas aeruginosa. Antimicrob. Agents Chemother., 1993, 37, 962-969.
48. ORSI G.-B., MANSI A., TOMAO P., CHIARINI F., VISCA P. Lack of association between clinical and environmental isolates of Pseudomonas aeruginosa in hospital wards. J. Hosp. Infect., 1994, 27, 49-60.
49. PHILIPPON A. - β-lactamases of Pseudomonas aeruginosa. In β-Lactamases : current perspectives (Livermore D., Ed). Theracom, the Hague, the Netherlands, 1988, pp 63-81.
50. PITT T.L. - Epidemiological typing of Pseudomonas aeruginosa. Eur. J Clin. Microbiol. Infect. Dis., 1988, 7, 238-247.
51. POLLACK M - Pseudomonas aeruginosa. In Principles and Practice of Infectious Diseases, Mandell G.-L., Douglas R.-G., and Benett J.-E. (ed.), 3rd ed. Churchill Livingstone. New York, 1995, pp. 1673-1691.
52. POOLE K., KREBESK., McNALLY C., NESHAT S. - Multiple antibiotic resistance in Pseudomonas aeruginosa : evidence for involvment of an efflux operon. J. Bacteriol., 1993, 175, 7363-7372.
53. QUINN J.-P., STUDEMEISTER A.-E., Di VINCENZO C.-A., LERNER S.-A. - Resistance to imipenem in Pseudomonas aeruginosa : clinical experience and biochemichal mechanisms. Rev. Infect. Dis., 1988, 10, 892-898.
54. RICHARD C., KIREDJIAN M. - Méthodes de laboratoire pour l'identification des bacilles à Gram négatif aérobies stricts., Paris, Institut Pasteur, 1992, pp 42-49.
55. RICHARD P., LE FLOCH R., CHAMOUX C., PANNIER M., ESPAZE E., RICHET H. - Pseudomonas aeruginosa outbreak in a burn unit : role of antimicrobials in the emergence of multiply resistant strains. J. Infect. Dis., 1994, 170, 377-383.
56. THABAUT A. - Pseudomonas aeruginosa et antibiotiques. J. Pharm Clin., 1988. 7, 39-53
57. THABAUT A. - Les antibiotiques anti-Pseudomonas aeruginosa en 1995 . éléments microbiologiques. Lett. Infectiol., 1995, X, n° 1: 14-19.
58. THABAUT A , MEYRAN M. - Pseudomonas aeruginosa : résistance acquise in vitro aux β-lactamines Path. Biol., 1983, 31, 387-391.
59. THABAUT A., MEYRAN M. - Activité bactéricide comparée de l'imipénème et d'autres antibiotiques sur Pseudomonas aeruginosa. Path. Biol., 1987, 36, 472-475.
60. THE INTERNATIONAL PSEUDOMONAS AERUGINOSA TYPING STUDY GROUP - A multicenter comparison of methods for typing strains of Pseudomonas aeruginosa predominently from patients with cystic fibrosis. J. Infect. Dis., 1993, 169, 134-142.
61. WATANABE M., IYOBE S., INOUE M., MITSUHASHI S. -Transferable imipenem resistance in Pseudomonas aeruginosa. Antimicrob. Agents Chemother., 1991. 35, 147-151.
62. WOLF M. - Antibiothérapie des infections à Pseudomonas aeruginosa. In L'infection en réanimation, sous la direction de Regnier B. et Brun-Buisson Ch., Massen (ed), Paris, 1988, pp. 230-241.
63. YONEZAWA M., TAKAHATA M., MATSUBARA N., WATANABE Y., NARITA H. - DNA gyrase gyrA mutation in quinolone-resistant clinical isolates of Pseudomonas aeruginosa. Antimicrob. Agents Chemother., 1995, 39, 1970-1972.
64. ZHOU X.-Y., KITZIS M.-D , GUTMANN L. - Role of cephalosporinase in carbapenem resistance of clinical isolates of Pseudomonas aeruginosa. Antimicrob. Agents Chemother, 1993. 37, 1387-1389.